Examiner: CHEU, CHANGHWA J

Tech Center 1600 • Art Units: 1641 1645 1677 1678

This examiner grants 75% of resolved cases

Performance Statistics

74.6%

Allow Rate

+14.6% vs TC avg

1,197

Total Applications

+47.4%

Interview Lift

972

Avg Prosecution Days

Based on 1193 resolved cases, 2023–2026

6.6%

§101 Eligibility

18.8%

§102 Novelty

32.7%

§103 Obviousness

29.6%

§112 Clarity

App #	Title	Status	Assignee
18336644	FAST PROTEIN SEQUENCING	Non-Final OA	Regeneron Pharmaceuticals, Inc.

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.